Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MYRIAD GENETICS INC Director's Dealing 2017

Nov 14, 2017

32566_dirs_2017-11-14_9f918dee-cd59-417f-8637-6dcfa67db7e7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2017-11-13

Reporting Person: Ford Alexander (President, MGL)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-11-13 Common Stock S 3031 $31.6388 Disposed 76769 Direct